Existing drug shows promise targeting common cancer mutation
Gizmag Emerging Technology Magazine,
Difficult to detect and with a low survival rate, pancreatic cancer is one of the most insidious forms of the disease. But now…
Difficult to detect and with a low survival rate, pancreatic cancer is one of the most insidious forms of the disease. But now…
A promising new cancer drug will soon enter phase 2 clinical trials, after finding success in animal models and preliminary…
スローンケタリング癌研究所・Samuel J. Danishefskyら共同研究グループは、Dーアミ